Early research (Phase 1)Study completedNCT02681861
What this trial is testing
Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects
Who this might be right for
Healthy SubjectsPharmacokinetics of ASP6294
Astellas Pharma Europe B.V. 74